Evidence map›Paper›PMID 32667867›Full record

ReviewAmerican journal of physiology. Cell physiology2020

Resolution of inflammation in immune and nonimmune cells by interleukin-19.

Tani Leigh, Rosario G Scalia, Michael V Autieri

Open access · bronzeAbstract readReview
In one paragraph

Review in American journal of physiology. Cell physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. An improved understanding of pediatric chronic nonbacterial osteomyelitis pathophysiology informs current and future treatment.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
    Review
  7. Article
  8. Immune Dysregulation in Endometriomas: Implications for Inflammation.International journal of molecular sciences · 2024
    Review
  9. Review
  10. TRP Ion Channels in Immune Cells and Their Implications for Inflammation.International journal of molecular sciences · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Systemic Cytokines in Retinopathy of Prematurity.Journal of personalized medicine · 2023
    Review
  15. A Comprehensive Analysis of Cytokine Network in Centenarians.International journal of molecular sciences · 2023
    Article
  16. Carbon Dots for the Treatment of Inflammatory Diseases: An Appraisal ofOxidative medicine and cellular longevity · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tani LeighDepartment of Physiology, Independence Blue Cross Cardiovascular Research Center, Lemole Center for Integrated Lymphatics Research, Temple University School of Medicine, Philadelphia, Pennsylvania.
Rosario G ScaliaDepartment of Physiology, Independence Blue Cross Cardiovascular Research Center, Lemole Center for Integrated Lymphatics Research, Temple University School of Medicine, Philadelphia, Pennsylvania.
Michael V AutieriDepartment of Physiology, Independence Blue Cross Cardiovascular Research Center, Lemole Center for Integrated Lymphatics Research, Temple University School of Medicine, Philadelphia, Pennsylvania.
Temple University · US

Funding

miRNA-mediated reduction of VSMC foam cell formationR01HL117724 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI AUTIERI, MICHAEL V · 2013 to 2022
$3.8M
Attenuation of atherosclerosis by regulation of VSMC inflammatory gene mRNA stabilityR01HL141108 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI AUTIERI, MICHAEL V · 2018 to 2021
$2.0M
NHLBI NIH HHS R01 HL117724
6 · The paper itself

Abstract

The inflammatory response is a complex, tightly regulated process activated by tissue wounding, foreign body invasion, and sterile inflammation. Over the decades, great progress has been made to advance our understanding of this process. One often overlooked aspect of inflammation is its sequel: resolution. We know that dysregulated resolution often results in numerous chronic degenerative diseases such as arthritis, cancer, and asthma. However, identification of components and mechanisms of resolving pathways lags behind those of proinflammatory processes, yet represents overlooked therapeutic opportunities. One approach is identification of endogenous, negative compensatory mechanisms, which are activated in response to inflammation for the purpose of resolution of that inflammatory stimuli. This review will focus on literature that describes expression and function of interleukin-19, a proposed anti-inflammatory cytokine, in numerous inflammatory diseases. The literature concerning IL-19 is complex, context-dependent, and often contradictory. The expression and function of IL-19 in the inflammatory response are in no way settled. We will attempt to clarify the role that this interesting and understudied cytokine plays in resolution of inflammation and discuss its mechanisms of action in different cell types. We will present a hypothesis that endogenous IL-19 expression in response to inflammatory stimuli is a cellular compensatory mechanism to dampen inflammation. We further present studies suggesting that while endogenously expressed IL-19 may be a response to inflammation, pharmacological levels may be necessary to effectively resolve the inflammatory cascade.

Indexed as

AnimalsAnti-Inflammatory AgentsCytokinesHumansInflammationInterleukinsAnti-Inflammatory AgentsCytokinesIL19 protein, humanInterleukinsFXR1inflammationinterleukin-19mRNA stabilityresolution

Identifiers

PMID32667867
PMCPMC7509264
OpenAlexW3042662473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.